MT1 melatonin receptors and their role in the oncostatic action of melatonin

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue

Abstract

Melatonin, the main hormone produced by the pineal gland, strongly inhibits the growth of cancer cells [i]in vitro[/i] and [i]in vivo[/i]. Some publications indicate that the addition of melatonin to culture medium slows the proliferation of some cancer cell lines. It is also suggested that melatonin used as an adjuvant benefits the effectiveness and tolerance of chemotherapy. The mechanisms of this are not fully understood, but melatonin receptors might be one of the most important elements. Two distinct types of membrane-bound melatonin receptors have been identified in humans: MT1 (Mel1a) and MT2 (Mel1b) receptors. These subtypes are 60% homologous at the amino-acid level. MT1 receptors are G-protein-coupled receptors. Through the α subunit of G protein, melatonin receptors stimulate an adenylate cyclase and decrease the level of cAMP. This has a significant influence on cell proliferation and has been confirmed in many tests on different cell lines, such as S-19, B-16 murine melanoma cells, and breast cancer cells. It seems that expression of the MT1 melatonin receptors benefits the efficacy of melatonin treatment. Melatonin and its receptors may provide a promising way to establish new alternative therapeutic approaches in human cancer prevention.

Authors and Affiliations

Karolina Danielczyk, Piotr Dzięgiel

Keywords

Related Articles

Activity of N-acetyl-β-hexosaminidase and its isoenzymes A and B in cancer

There were approximately 93,060 deaths from cancers in Poland in 2008, and about 105,000 are predicted for the year 2025. Early detection of cancer is a major problem throughout the world, which is why many researchers a...

Helicobacter pylori morphological forms and their potential role in the transmission of infection

More than 50% of the world’s population is infected with Helicobacter pylori (H. pylori) – a Gram negative bacterium, which persists in the human stomach and duodenum, causing gastric or duodenal ulcers and gastric cance...

Dakarbazyna jako lek przeciwczerniakowy i referencyjny dla nowych programów terapeutycznych

Czerniak jest nowotworem wywodzącym się z melanocytów, komórek pochodzenia neuroektodermalnego. Leczenie pacjentów z czerniakiem jest trudne ze względu na agresywny przebieg choroby oraz wczesne i liczne przerzuty. Podst...

Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG

The neonatal Fc receptor, (FcRn) is a transmembrane, heterodimeric glycoprotein with a structure similar to MHC class I molecules. In contrast to MHC class I antigens, FcRn does not bind to peptides (antigens) but intera...

Download PDF file
  • EP ID EP66374
  • DOI -
  • Views 189
  • Downloads 0

How To Cite

Karolina Danielczyk, Piotr Dzięgiel (2009). MT1 melatonin receptors and their role in the oncostatic action of melatonin. Advances in Hygiene and Experimental Medicine, 63(), 425-434. https://europub.co.uk/articles/-A-66374